Pharos Capital Group, LLC, a private equity firm, has invested in Sanderling Renal Services, a provider of telemedicine services.
The investment will support Sanderling’s home dialysis operations and the implementation of telemedicine.
Dr. Jerome Tannenbaum, chairman of Sanderling, said, “We are pleased to work with such an experienced, healthcare-focused partner to help Sanderling reach new goals in the next phase of its growth. Pharos’s significant resources and proven track record guiding value-based healthcare organizations will be invaluable as Sanderling expands services in existing markets, moves into new communities, and broadens its telemedicine and eDialysis offerings.”
MTS Health Partners, L.P. served as financial advisor to Sanderling on the transaction.